Avanos Medical, Inc. (NYSE:AVNS) Q2 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Avanos Second Quarter 2025 Earnings Conference Call.
Avanos Medical Inc. (AVNS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Paradice Investment Management David Paradice | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.00 | 40,000 | $439,800.00 | 40,000 | 2025-08-13 | Filing | |
| $10.98 | 20,000 | $219,500.00 | 91,593 | 2025-08-13 | Filing | |
| $19.85 | 500 | $9,925.00 | 50,090 | 2024-03-11 | Filing | |
| $31.67 | 800 | $25,336.00 | 33,900 | 2021-09-15 | Filing | |
| $31.65 | 900 | $28,485.00 | 33,100 | 2021-09-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.25 | 7,000 | $106,778.00 | 82,047 | 2025-03-06 | Filing | |
| $19.16 | 110 | $2,107.60 | 151,495 | 2024-03-14 | Filing | |
| $19.15 | 808 | $15,473.20 | 151,605 | 2024-03-14 | Filing | |
| $19.14 | 337 | $6,450.18 | 152,413 | 2024-03-14 | Filing | |
| $19.13 | 2,231 | $42,679.03 | 152,750 | 2024-03-14 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 328,805 | $3,800,986 | 0.01% | |
| 2. | 138,233 | $1,597,973 | 0% | |
| 3. | 49,404 | $571,110 | 0% | |
| 4. | 39,958 | $461,915 | 0% | |
| 5. | 21,300 | $246,228 | 0% |
News See All
10 Undervalued Medical Device Stocks to Buy Now
According to a report by Mordor Intelligence, the medical device industry is valued at $681.57 billion as of 2025.
Avanos Medical, Inc. (NYSE:AVNS) Q1 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Avanos Medical, Avanos First Quarter 2025 Earnings Call. [Operator Instructions] This call is being recorded on Tuesday, May 6, 2025.
Avanos Medical (AVNS): Positioned for Growth Under New Leadership
Diamond Hill Capital, an investment management company, released its “Small Cap Fund” first-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Avanos Medical, Inc. (NYSE:AVNS) Q4 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. Welcome to the Avanos Medical, Inc. fourth quarter 2024 earnings call. At this time, all lines are in listen-only mode.
Avanos (AVNS) Declined due to Reduced Earnings Guidance
Rewey Asset Management, an investment management company, released its “RAM Smid Composite” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
Avanos Medical, Inc. (NYSE:AVNS) Q3 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Avanos Medical, Avanos Third Quarter 2024 Earnings Call.
Avanos Medical, Inc. (NYSE:AVNS) Q2 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Avanos Medical Q2 2024 Earnings Call. At this time, all lines are in a listen-only mode.
Avanos Medical, Inc. (NYSE:AVNS) Q1 2024 Earnings Call Transcript
Operator: Good morning ladies and gentlemen and welcome to the Avanos First Quarter 2024 Earnings Conference. At this time, all lines are in a listen-only mode.
Avanos Medical, Inc. (NYSE:AVNS) Q4 2023 Earnings Call Transcript
Avanos Medical, Inc. misses on earnings expectations. Reported EPS is $0.32 EPS, expectations were $0.37.
Hedge Fund Resource Center Billionaire Hedge Funds
